Panagiotis Iliakis: The Emerging Role of Recreational Drugs in Acute Coronary Syndrome
Panagiotis Iliakis, Interventional Cardiology and Research Fellow at Knappschaft Kliniken Universitätsklinikum Bochum, Fellow of European Society of Hypertension (FESH) at ESH, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Medicina MDPI, adding:
“We are happy to share our latest article entitled ‘Acute Coronary Syndrome and Recreational Drug Use: A Comprehensive Review’, just published in Medicina MDPI.
- Recreational drug use is increasingly recognized as an important and frequently under-reported trigger of acute coronary syndrome (ACS), particularly among younger patients with few or no conventional cardiovascular risk factors.
- Cocaine, cannabis, amphetamines, methamphetamine, opioids, synthetic cannabinoids, and other substances may precipitate myocardial ischaemia through several mechanisms, including coronary vasospasm, sympathetic activation, endothelial dysfunction, enhanced platelet aggregation, thrombosis, accelerated atherosclerosis, and direct myocardial toxicity.
- Diagnosis and management remain challenging because patients may present with overlapping mechanisms of myocardial injury, uncertain substance exposure, and limited evidence supporting drug-specific therapeutic strategies. Greater clinical awareness and systematic assessment of recreational drug use are therefore essential in patients presenting with ACS.
Our review discusses the epidemiology, underlying pathophysiological mechanisms, clinical presentation, diagnostic approach, therapeutic considerations, and current evidence gaps related to recreational drug-associated acute coronary syndromes.”
Title: Acute Coronary Syndrome and Recreational Drug Use: A Comprehensive Review
Authors: Panagiotis Iliakis, Konstantina Ntalekou, Eleftheria Stamou, Aikaterini-Eleftheria Karanikola, Andreas Mavroudis, Nikolaos Ktenopoulos, Paschalis Karakasis, Panagiotis Theofilis, Obayda Azizy, Anna Pitsillidi, Aikaterini Damianaki, Eirini Beneki, Alexandros Kasiakogias, Christina Chrysohoou, Polykarpos Christos Patsalis, Kyriakos Dimitriadis, Konstantinos Tsioufis
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 5, 2026, 18:57Maria Luszczyn: Does Blood Transfusion Really Worsen Long-Term Survival after CABG or is Preoperative Anemia the Main Driver?
-
Nov 5, 2026, 18:20Jessica Vega: How Listening to Patient Experience Reframes Warm Autoimmune Hemolytic Anemia Care
-
Nov 5, 2026, 18:15Paresh P Kulkarni: Frontiers in Immunology Launches Call for Papers on Innate Immune Mechanisms and Biomarkers in APS
-
Nov 5, 2026, 18:08Perrine Henry: Iliac Venous Thrombus Identified as Rare Cause of Hindlimb Lameness in Dog with Primary Erythrocytosis
-
Nov 5, 2026, 18:02Kellie Machlus: Bone Marrow Megakaryocytes Present Antigens and Regulate T Cells
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe
-
Nov 5, 2026, 14:17Joshua Muia: The Evolution of ADAMTS13 Research
-
Nov 5, 2026, 14:02Paulo Colimodio: Scientific Highlights from the XVII Argentine Congress of Hemostasis and Thrombosis